ホーム
探索
nav.journalClub
トレンド
その他
synapse
⌘+K
言語
日本語
Peripheral T-cell Lymphoma Hematopoietic Stem Cell Transplant Outcomes at a Military Treatment Facility over 20 Years. | Synapse
March 3, 2026
Peripheral T-cell Lymphoma Hematopoietic Stem Cell Transplant Outcomes at a Military Treatment Facility over 20 Years.
SG
Steven J. Gibson
NR
Niels A. Ryden
GA
Gilbert Patrick Ancira
Joint Base San Antonio
See all
Key Points
Outcomes show significant improvements over a 20-year period in patients receiving hematopoietic stem cell transplants for peripheral T-cell lymphoma.
At a military treatment facility, the transplant success rate increased, with more patients achieving remission compared to initial records.
Assessment using long-term data from a military treatment center demonstrated the effectiveness of stem cell transplants over two decades.
Highlighting the need for further studies in diverse settings to confirm these outcomes and understand variability in different populations.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Gibson et al. (Sun,) studied this question.
synapsesocial.com/papers/69a75ffec6e9836116a2c60e
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.549